Angiodrastic Chemokines in Colorectal Cancer: Clinicopathological Correlations

Analytical Cellular Pathology (Amsterdam)
George EmmanouilElias Kouroumalis

Abstract

To study the expression of angiodrastic chemokines in colorectal tumors and correlate findings with clinicopathological parameters and survival. The proangiogenic factor VEGF, the angiogenic chemokines CXCL8 and CXCL6, and the angiostatic chemokine CXCL4 were measured by ELISA in tumor and normal tissue of 35 stage II and III patients and correlated with the histopathology markers Ki67, p53, p21, bcl2, EGFR, and MLH1 and 5-year survival. The Wilcoxon and chi-square tests were used for statistical comparisons. There was a significant increase of CXCL6 (p = 0.005) and VEGF (p = 0.003) in cancerous tissue compared to normal. Patients with lower levels of CXCL8 and CXCL4 lived significantly longer. Patients with loss of EGFR expression had higher levels of CXCL8 while p21 loss was associated with higher levels of CXCL6. Chemokine levels were not correlated with TNM or Dukes classification. Strong expression of p53 was accompanied by decreased survival. (1) The angiogenic factors CXCL6 and VEGF are increased in colorectal cancer tissue with no association with the clinical stage of the disease or survival. (2) However, increased levels of tissue CXCL8 and CXCL4 are associated with poor survival. (3) Strong expression of p53 is found...Continue Reading

References

Oct 1, 1985·Analytical Biochemistry·P K SmithD C Klenk
Nov 10, 1995·The Journal of Biological Chemistry·R M StrieterD Marriott
Dec 1, 1994·The American Journal of Physiology·C P KellyH R Brady
Sep 1, 1995·Shock·R M StrieterS L Kunkel
Nov 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R BrewS E Christmas
Jun 20, 1997·International Journal of Cancer. Journal International Du Cancer·U ManneW E Grizzle
Nov 19, 1997·Journal of Leukocyte Biology·J Van DammeG Opdenakker
Mar 4, 1998·European Journal of Immunology·M WolfM Baggiolini
Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·H SotoA Zlotnik
Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Mar 29, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carmen J AllegraRichard M Goldberg
Jul 16, 2002·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Giovanni LanzaLuigi Cavazzini
Mar 11, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Aihua LiRakesh K Singh
Jul 11, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F Graziano, S Cascinu
Jun 4, 2004·The New England Journal of Medicine·Thierry AndréUNKNOWN Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC)
Jun 4, 2004·International Journal of Colorectal Disease·Seok-Byung LimJae-Gahb Park
Oct 23, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Ruth SchrueferBarbara Walzog
Nov 19, 2004·Cancer Research·Thomas D ShellenbergerMitchell J Frederick
Jan 22, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S PopatR S Houlston
Jul 1, 2005·The New England Journal of Medicine·Chris TwelvesWerner Scheithauer
Jul 28, 2005·Cytokine & Growth Factor Reviews·Robert M StrieterMichael P Keane
Aug 10, 2005·European Surgical Research. Europäische Chirurgische Forschung. Recherches Chirurgicales Européennes·H TeradaH Konno
Jan 10, 2006·Diseases of the Colon and Rectum·Marja HilskaPeter J Roberts
Feb 21, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Matthew S LyallGraeme I Murray
Apr 22, 2006·Contributions to Microbiology·Brigitte N Gomperts, Robert M Strieter
Sep 5, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marcin Kowanetz, Napoleone Ferrara
Feb 27, 2007·Vascular Health and Risk Management·Roberta W C Pang, Ronnie T P Poon
Sep 15, 2007·World Journal of Gastroenterology : WJG·Claudia RubieMartin K Schilling
Sep 18, 2007·European Journal of Gastroenterology & Hepatology·Hiroyuki MitomiKatsunori Saigenji

❮ Previous
Next ❯

Methods Mentioned

BETA
surgical resection
ELISA

Software Mentioned

SPSS

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.